US Stock MarketDetailed Quotes

Lexicon Pharmaceuticals (LXRX)

Watchlist
  • 2.440
  • +0.030+1.24%
Close May 13 16:00 ET
  • 2.420
  • -0.020-0.82%
Post 19:50 ET
1.08BMarket Cap-34.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexicon Pharmaceuticals (LXRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
1,572.11%21.1M
60.24%49.8M
-79.31%5.49M
710.40%14.18M
1,652.64%28.87M
11.68%1.26M
2,481.48%31.08M
3,682.62%26.55M
980.25%1.75M
419.56%1.65M
Operating revenue
1,572.11%21.1M
60.24%49.8M
-79.31%5.49M
710.40%14.18M
1,652.64%28.87M
11.68%1.26M
2,481.48%31.08M
3,682.62%26.55M
980.25%1.75M
419.56%1.65M
Cost of revenue
260.00%108K
-55.52%274K
-42.24%201K
-85.92%10K
-80.12%33K
-3.23%30K
624.71%616K
397.14%348K
914.29%71K
1,975.00%166K
Gross profit
1,604.06%20.99M
62.58%49.53M
-79.81%5.29M
744.07%14.17M
1,846.86%28.83M
12.10%1.23M
2,622.52%30.47M
4,046.52%26.21M
983.23%1.68M
379.29%1.48M
Operating expense
-18.29%21.99M
-56.75%98.44M
-65.95%20.07M
-59.68%26.36M
-55.84%25.1M
-42.04%26.91M
31.65%227.58M
24.43%58.94M
31.31%65.37M
27.58%56.84M
Selling and administrative expenses
-20.45%9.23M
-73.92%37.32M
-72.85%8.76M
-80.80%7.6M
-76.14%9.35M
-63.79%11.61M
25.55%143.1M
-1.07%32.26M
22.85%39.59M
30.61%39.19M
Research and development costs
-16.64%12.76M
-27.65%61.12M
-57.60%11.32M
-27.24%18.76M
-10.75%15.75M
6.48%15.3M
43.46%84.48M
80.77%26.69M
46.83%25.78M
21.33%17.64M
Operating profit
96.12%-996K
75.19%-48.91M
54.85%-14.78M
80.87%-12.19M
106.75%3.74M
43.35%-25.68M
-14.77%-197.12M
29.95%-32.74M
-28.33%-63.69M
-25.12%-55.35M
Net non-operating interest income expense
-112.24%-47K
56.48%-1.43M
27.11%-750K
47.94%-582K
-125.14%-484K
112.53%384K
38.80%-3.29M
65.92%-1.03M
-25.06%-1.12M
389.91%1.93M
Non-operating interest income
-30.46%1.54M
-43.80%6.91M
-54.72%1.28M
-54.33%1.57M
-55.66%1.83M
17.78%2.22M
58.99%12.29M
17.78%2.83M
14.61%3.44M
219.14%4.14M
Non-operating interest expense
-13.35%1.59M
-46.47%8.34M
-47.36%2.03M
-52.76%2.16M
4.84%2.32M
-62.91%1.84M
18.91%15.58M
-28.83%3.86M
17.00%4.56M
12.81%2.21M
Other net income (expense)
Income before tax
95.88%-1.04M
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
Income tax
Net income
95.88%-1.04M
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
Net income continuous Operations
95.88%-1.04M
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
Minority interest income
Net income attributable to the parent company
95.88%-1.04M
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
95.88%-1.04M
74.88%-50.34M
54.01%-15.53M
80.30%-12.77M
106.09%3.25M
47.73%-25.3M
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
Basic earnings per share
0
77.78%-0.14
55.56%-0.04
77.78%-0.04
105.88%0.01
65.00%-0.07
21.25%-0.63
55.00%-0.09
14.29%-0.18
22.73%-0.17
Diluted earnings per share
0
77.78%-0.14
55.56%-0.04
77.78%-0.04
105.88%0.01
65.00%-0.07
21.25%-0.63
55.00%-0.09
14.29%-0.18
22.73%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 1,572.11%21.1M60.24%49.8M-79.31%5.49M710.40%14.18M1,652.64%28.87M11.68%1.26M2,481.48%31.08M3,682.62%26.55M980.25%1.75M419.56%1.65M
Operating revenue 1,572.11%21.1M60.24%49.8M-79.31%5.49M710.40%14.18M1,652.64%28.87M11.68%1.26M2,481.48%31.08M3,682.62%26.55M980.25%1.75M419.56%1.65M
Cost of revenue 260.00%108K-55.52%274K-42.24%201K-85.92%10K-80.12%33K-3.23%30K624.71%616K397.14%348K914.29%71K1,975.00%166K
Gross profit 1,604.06%20.99M62.58%49.53M-79.81%5.29M744.07%14.17M1,846.86%28.83M12.10%1.23M2,622.52%30.47M4,046.52%26.21M983.23%1.68M379.29%1.48M
Operating expense -18.29%21.99M-56.75%98.44M-65.95%20.07M-59.68%26.36M-55.84%25.1M-42.04%26.91M31.65%227.58M24.43%58.94M31.31%65.37M27.58%56.84M
Selling and administrative expenses -20.45%9.23M-73.92%37.32M-72.85%8.76M-80.80%7.6M-76.14%9.35M-63.79%11.61M25.55%143.1M-1.07%32.26M22.85%39.59M30.61%39.19M
Research and development costs -16.64%12.76M-27.65%61.12M-57.60%11.32M-27.24%18.76M-10.75%15.75M6.48%15.3M43.46%84.48M80.77%26.69M46.83%25.78M21.33%17.64M
Operating profit 96.12%-996K75.19%-48.91M54.85%-14.78M80.87%-12.19M106.75%3.74M43.35%-25.68M-14.77%-197.12M29.95%-32.74M-28.33%-63.69M-25.12%-55.35M
Net non-operating interest income expense -112.24%-47K56.48%-1.43M27.11%-750K47.94%-582K-125.14%-484K112.53%384K38.80%-3.29M65.92%-1.03M-25.06%-1.12M389.91%1.93M
Non-operating interest income -30.46%1.54M-43.80%6.91M-54.72%1.28M-54.33%1.57M-55.66%1.83M17.78%2.22M58.99%12.29M17.78%2.83M14.61%3.44M219.14%4.14M
Non-operating interest expense -13.35%1.59M-46.47%8.34M-47.36%2.03M-52.76%2.16M4.84%2.32M-62.91%1.84M18.91%15.58M-28.83%3.86M17.00%4.56M12.81%2.21M
Other net income (expense)
Income before tax 95.88%-1.04M74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M
Income tax
Net income 95.88%-1.04M74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M
Net income continuous Operations 95.88%-1.04M74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M
Minority interest income
Net income attributable to the parent company 95.88%-1.04M74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 95.88%-1.04M74.88%-50.34M54.01%-15.53M80.30%-12.77M106.09%3.25M47.73%-25.3M-13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M
Basic earnings per share 077.78%-0.1455.56%-0.0477.78%-0.04105.88%0.0165.00%-0.0721.25%-0.6355.00%-0.0914.29%-0.1822.73%-0.17
Diluted earnings per share 077.78%-0.1455.56%-0.0477.78%-0.04105.88%0.0165.00%-0.0721.25%-0.6355.00%-0.0914.29%-0.1822.73%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -